A localized outbreak, even a fatal one, is unlikely to spark the multibillion-dollar revenue catalyst that Moderna needs.
Moderna Stock Is Surging on Hantavirus Threats. Its Chart Offers a Harsh Dose of Reality.
A localized outbreak, even a fatal one, is unlikely to spark the multibillion-dollar revenue catalyst that Moderna needs.